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The design of studies examining the relation
between environmental exposures and
human health, including subtle markers of
human reproduction, usually incorporates
the collection of one or more biospecimens
from study participants. Such specimens can
both minimize misclassification bias associ-
ated with exposure or disease status and pro-
vide cellular and molecular data that can
contribute to an understanding of the physi-
ological processes being impacted. However,
a major complicating factor for studies col-
lecting biospecimens, especially large popula-
tion-based studies such as the proposed
National Children’s Study (NCS 2003), is
that sample collection can be encumbered by
the logistics and expense of obtaining
biospecimens from participants who live in a
variety of locations and lead a variety
of lifestyles. 
One way to address this issue may be to
incorporate home-based collection proto-
cols that can be carried out by study partici-
pants with minimal to no oversight from
study staff members. Such approaches have
been widely if somewhat erratically used in
previous epidemiologic studies. However, to
our knowledge there has been neither dis-
cussion in the scientific literature on the
utility or extent of the practice nor any
assessment of its value in large longitudinal
studies such as the NCS. We present a gen-
eral overview of the utility of biospecimens
and discuss those currently amenable to
home collection, including how they can be
collected and the type of research data they
can yield.
Impact on Recruitment and
Compliance Rates
One of the most useful aspects of home collec-
tion of biospecimens is the possible improve-
ment of participant response. For example, a
study by van Valkengoed et al. (2002) showed
that in a screening program for asymptomatic
Chlamydia trachomatis infections, mailing
urine samples, as opposed to bringing them to
the clinic, increased participation of male sub-
jects by 18% (although no difference was
noted among female participants). In another
study, participation in a protocol to collect oral
rinse samples was greater in the home-based
group than in the clinic-based collection group
(98% vs. 71%, respectively) (Harty et al.
2000b). There are several plausible reasons for
this observed increase in participation by the
home-based groups, primarily related to
increased convenience for the participant.
Special trips to the clinic are not required, and
specimen acquisition and/or testing are per-
formed in the privacy of the participant’s
home and at his/her convenience. In some
cases the lack of interaction with the clinical
environment may also add to a feeling of
anonymity for the participant. For the afore-
mentioned reasons, one could reasonably
hypothesize that participation rates would be
higher in studies using home-collection proto-
cols than those requiring participants to attend
clinics for specimen collection. However, at
this time studies are insufﬁcient to conﬁrm this
hypothesis, suggesting that such a study,
encompassing different samples and different
socioeconomic groups, would be well received
and of great benefit to future epidemiologic
research studies.
Feasibility Issues for
Home-Based Collection
of Biospecimens
When weighing the decision whether to use
home-based biospecimen collection, investi-
gators must consider ﬁve main issues:
• Specimen collection
• Specimen storage
• Transportation of the specimen to the clinic
or analytical laboratory
• Stability of the specimen between collection
and delivery
• Reception, storage, and analysis of the speci-
men in the laboratory
To address these issues, investigators must
first determine the specifice use for these
biospecimen(s). This in turn will determine
how much sample will be needed, how it
should be collected, when it should be col-
lected, and how it should be stored and trans-
ported. Another consideration in feasibility
assessment is the need for quality control of the
samples to ensure their usefulness. Because
many sources of error can be introduced in the
collection and storage of biospecimens (Boone
et al. 1995; Plebani and Carraro 1997), stan-
dard operating procedures must be developed
and implemented regardless of whether speci-
mens collected in the home are procured by
research staff or by study volunteers themselves.
Specific protocols must be prepared with
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Detection, quantification, and prognosis of environmental exposures in humans has been vastly
enhanced by the ability of epidemiologists to collect biospecimens for toxicologic or other labora-
tory evaluation. Ease of collection and level of invasiveness are commonly cited reasons why
study participants fail to provide biospecimens for research purposes. The use of methodologies
for the collection of biospecimens in the home offers promise for improving the validity of health
effects linked to environmental exposures while maximizing the number and type of specimens
capable of being collected in a timely and cost-effective manner. In this review we examine
biospecimens (urine and blood) that have been successfully collected from the home environ-
ment. Related issues such as storage and transportation will also be examined as well as promis-
ing new approaches for collecting less frequently studied biospecimens (including hair follicles,
breast milk, semen, and others). Such biospecimens are useful in the monitoring of reproductive
development and function. Key words: biospecimen, blood, breast milk, buccal cells, hair, home
collection, nail, reproduction, saliva, semen, tissue collection, urine. Environ Health Perspect
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2003]simple, clear instructions suitable for people at
all levels of education and that (in some cases)
can be conducted unsupervised within the lim-
its and with the equipment found in a residen-
tial dwelling. This means, for example, that for
unsupervised home collections, toxic substances
should not be included in collection kits, and
samples should be amenable to storage at room
temperature 4°C or –20°C.
Biospecimens Amenable 
to Home Collection
An eclectic body of work on both the acquisi-
tion and analysis of home-collected samples
has emerged over the past few years. The
most common biospecimens collected by
investigators to date are urine, blood, and
semen. In most cases, these and a number of
other samples can be collected in the home
(Table 1). In the next section, we discuss the
types of data these samples can provide and
the issues related to their collection and
transportation.
Urine. What can be measured in urine?
Urine is one of the biospecimens most
amenable to home collection. Many currently
used biomarkers of reproductive health such as
steroid hormones or their metabolites can be
measured in urine. Because hormones play such
a vital role in the maintenance of reproductive
health, knowledge of an imbalance in one or
more hormones can help illuminate the cause
of health problems. In particular, the levels of
these hormones are excellent indicators for
studying various aspects of the female reproduc-
tive cycle. For example, daily sampling of urine
throughout the menstrual cycle can assist in the
evaluation of the dynamic functions of
the hypothalamo–hypophysial–ovarian axis
(Kesner et al. 1999; Scialli et al. 1997). Relative
levels of steroid hormones in urine can also be
used to estimate the day of ovulation through
measurement of luteinizing hormone (LH, the
basis for most commercially available ovula-
tion predictor kits) (Kesner et al. 1998), or
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Table 1. Biospecimens amenable to collection in the home environment.
Biospecimen Collection by Storage Transportation Target analytes
Blood Trained phlebotomists Ambient temperature  Study staff collect and deliver Biochemical agents (e.g., hormones)
Ice specimens to laboratory Chemicals (e.g., solvents)
N.B., assays can be sensitive  Mail options for ﬁlter paper  Chemical metabolites (e.g.,
to temperature, shaking and 3,5,6- trichloro-2-pyridinol)
processing Drugs 
Drug metabolites (e.g., cotinine)
Breast milk Female study participants Freezer Study staff collect and deliver Chemicals (e.g., p,p´-DDT)
Refrigerator specimens to laboratory  Chemical metabolites (e.g., p,p´-DDE)
Study participant transports 
sample to clinic
Mailed on dry ice or with 
freezer pack
Buccal cells Study participants If collected in mouthwash Study staff collect and deliver DNA for genotyping
Study staff members or cytobrush: specimens to laboratory Immunoassays
Up to 1 week at 37ºC  Study participant transports Chemicals (e.g., solvents)
sample to clinic
Mail options
Hair/nail Study participants Freezer Study staff collect and deliver Heavy metals
Study staff members Refrigerator specimens to laboratory
Room temperature Study participant transports
sample to clinic
Mail options
Hair follicles Study participants If collected in RNA later: Study staff collect and deliver DNA for genotyping
Study staff members Freezer—indeﬁnitely specimens to laboratory RNA for gene expression analysis
Refrigerator—1 month Study participant transports
Room temperature—1 week  sample to clinic
Mail options
Saliva Study participants Freezer Study staff collect and deliver Steroid hormones
Study staff members Up to 1 week at specimens to laboratory
room temperature Study participant transports
sample to clinic
Mailed on dry ice (preferable) 
or with freezer pack (preferable) 
or at ambient temperature
Semen Male study participants Up to 1 day ambient or Study staff collect and deliver Biological agents (sperm parameters)
refrigerated for most measures specimens to laboratory Biochemical agents (e.g., hormones)
Freezer for genomic  Study participant transports Metals (e.g., lead, cadmium) 
integrity assays sample to clinic Chemical metabolites (e.g., 
Mail options p-chlorophenyl ethane)
Urine Study participants Freezer Study staff collect and deliver Biological agents (microbes)
Refrigerator specimens to laboratory Biochemical agents (e.g., hormones)
Study participant transports  Chemicals (e.g., solvents)
sample to clinic Chemical metabolites (e.g., 3,5,6-
Mail options for ﬁlter paper  trichloro-2-pyridinol)
or frozen specimens  Drugs 
Drug metabolites (e.g., cotinine)
Vaginal swabs Female study participants Freezer Study staff collect and deliver Biological agents (microbes)
Study staff members specimens to laboratory
Study participant transports 
sample to clinic
Mail optionsthe relative concentrations of estrogen and
progesterone metabolites in daily ﬁrst-morning
urine specimens (Baird et al. 1991, 1995).
Pregnancy can of course be detected quickly
and conveniently using kits that detect the
sharp rise in urine of human chorionic
gonadotropin (hCG). Because commercially
available home pregnancy test kits are sensitive,
speciﬁc (Ehrenkranz 2002), and easy to use, at
least one study has used them in lieu of urine
collection to ascertain early pregnancy losses
(Buck et al. 2002). Wilcox and colleagues
(2001) recently reported that home pregnancy
kits may have a false positive rate of 10% when
used the ﬁrst day after expected menstruation
(assuming ovulation is delayed). Corroboration
of these findings will underscore the impor-
tance of estimating ovulation in protocols
involved in day-speciﬁc exposures or outcomes.
Unfortunately, the relation between
urinary hormone metabolites and abnormal
reproductive function has not been well char-
acterized across populations and particularly
susceptible subgroups of the population or in
individuals from disadvantaged or medically
underserved backgrounds. As urinary hormone
metabolites are not commonly reported during
the evaluation of reproductive problems, Lasley
and Overstreet (1998) called for clinical studies
to compare concentrations in urine and blood
as a first step in validating this approach.
Nevertheless, numerous studies have been con-
ducted on the actual measurement of reproduc-
tive hormones in urine, many of which are
summarized in the Lasley and Overstreet
review. Many of these assays have been reﬁned
over the past 10 years, making them cost effec-
tive, robust, and accurate. Furthermore, many
are available commercially as kits for use at
home by untrained personnel [e.g., for measur-
ing estradiol and progesterone metabolites, LH,
follicle-stimulating hormone (FSH), and hCG].
Steroid hormone data are not the only
information that can be derived from urinary
samples. An enormous range of biological, bio-
chemical, and chemical substances can be
detected in urine (e.g., CDC 2003), including
microbes, pesticides, solvents, and drugs. It has
long been known that microbial infection dur-
ing gestation can adversely impact fetal devel-
opment (e.g., Rubella) and in some cases may
result in death (Embleton 2001). Such infec-
tions can sometimes be detected in the urine of
parents through the use of enzyme-linked
immunosorbent, ligase chain reaction, or poly-
merase chain reaction (PCR) assays. A variety
of viruses (papillomavirus, hepatitis B virus,
HIV, cytomegalovirus, polyomavirus, adeno-
virus), bacteria (Neisseria gonorrhoeae and
Chlamydia trachomatis), and mycoplasma
(Mycoplasma genitalium) can be detected in this
way. Furthermore, because of the stability of
DNA and the robustness of the PCR process,
assays for infections such as cytomegalovirus
can be performed on urine collected on ﬁlter
paper (Yamamoto et al. 2001). This has the
potential to facilitate shipping (it is easier to
ship filter papers than specimen collection
vials), reduce the biohazard potential of the
sample during transportation (sample is effec-
tively transported as a solid and therefore can-
not leak), and make storage of the sample at
the analytical facility more convenient.
Exposure to pesticides before or during
pregnancy can adversely impact development,
leading to impaired neurological, immunolog-
ical, and reproductive function in the off-
spring (reviewed by Sever et al. 1997). For
example, male and female greenhouse workers
exposed to certain pesticides have an increased
time to pregnancy compared with that of
unexposed workers (Abell et al. 2000a, 2000b;
Petrelli and Figa-Talamanca 2001). For chil-
dren born to a cohort of male pesticide appli-
cators, significantly more birth defects
occurred in children conceived in the spring
than in any other season (Garry et al. 2002).
In the same study there was a modest but sig-
nificant increase in risk (1.6- to 2-fold) for
miscarriages and/or fetal loss occurring
throughout the year, suggesting a potential
association between pesticide exposure and
reproductive outcome. In most cases it is
unknown whether this connection is through
a direct toxic effect on parental gametes or
reproductive organs, an adverse impact on the
paternal or maternal endocrine system, or
direct toxicity to the developing embryo/fetus.
However, it is clear that the ability to measure
pesticide metabolites in urine may help
explain delayed conceptions, aborted pregnan-
cies, and developmental problems by deter-
mining if one or both partners have been
exposed to pesticides. Many different pesti-
cides have been measured in urine (reviewed
by Aprea et al. 2002). They are generally
measured using methods such as mass spec-
trometry, liquid chromatography–mass spec-
trometry, gas chromatography with electron
capture, gas chromatography–mass spectro-
metry, or high performance liquid chromato-
graphy. For example, exposure to the
organophosphorus pesticides chlorpyrifos and
chlorpyrifos-methyl can be determined by
measuring their specific metabolite, 3,5,6-
trichloro-2-pyridinol, in urine samples (Koch
et al. 2001).
As with pesticides, solvent exposure can
lead to reduced fecundibility in both males
(Cherry et al. 2001) and females (Sallmen et al.
1995) and lead to developmental problems
when exposure occurs in utero (Scheeres and
Chudley 2002; reviewed by Lindbohm 1995).
Again, exposure to solvents can be detected in
urine samples either directly or by measuring
metabolites or biomarkers. For example,
several investigators have measured toluene
exposure in urine, using benzylmercapturic
acid (Inoue et al. 2002), hippuric acid, o-cresol,
and toluene itself (Kawai et al. 1996).
Analysis of cotinine (a metabolite of nico-
tine) in urine is used frequently as an indicator
of exposure to cigarette smoke (active or pas-
sive), although blood or semen can be substi-
tuted for urine in this regard (Vine et al.
1993). Such exposures can have an adverse
impact on fertilization and embryo develop-
ment and are therefore of potential interest in
fertility and pregnancy studies. 
How can collection of urine be conducted
in the home environment? Using simple col-
lection protocols and storage procedures that
are complicit with the facilities available in the
home of an average study participant, investi-
gators found that hormones [e.g., LH and
FSH (Kesner et al. 1998, 1999)], solvents [e.g.,
benzene and toluene (Senzolo et al. 2001)],
pesticides [e.g., 2,4-dichlorophenoxyacetic acid
(Hu et al. 2000)], and/or metabolic products
thereof [e.g., organophosphorous pesticides
(Curl et al. 2003; Hu et al. 2000)] are stable in
urine. Hence, home collection of urine samples
by study volunteers is a feasible sampling
approach (Macleod et al. 1999), and various
protocols have been developed that create
minimal inconvenience for study participants.
When samples are collected at home, they are
typically stored frozen. Freezing allows storage
of a large sample volume, and multiple samples
can be accrued and/or combined. Thus, the
number of analytical measurements that can be
made is essentially unlimited. In a study by
Reutman et al. (2002), first morning urine
samples were collected into vials containing
glycerol at a final concentration of 7%. The
glycerol prevents freeze-induced activity loss of
LH and FSH (Kesner et al. 1995). The sam-
ples were stored in the participant’s freezer
(–20°C) until the end of the study, then
shipped en masse in dry ice by express courier
to the analytical laboratory. LH, FSH, estrone
3-glucuronide (a metabolite of estradiol), and
pregnanediol 3-glucuronide (a metabolite of
progesterone) were all successfully measured in
these samples.
Although reproductive hormones are fairly
stable in urine and home collection of urine
for metabolite analysis has been carried out in
collection vials such as those described above,
a more convenient method for a large longitu-
dinal cohort study might be to develop a sys-
tem for home collection of urine samples on
ﬁlter paper. Such samples would be even easier
to store until collection or mailing. In most
cases they could be mailed in an envelope at
ambient temperature, speeding delivery and
minimizing costs. Furthermore, storage of ﬁl-
ter paper requires less space than vials, an
important consideration for long-term studies
where tens or hundreds of thousands of sam-
ples are accumulated. Such a convenient
system would facilitate daily or more frequent
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study participants. The question remains as to
what can be measured from such biospeci-
mens. Shideler et al. (1995) used samples col-
lected on filter paper for analyzing steroid
hormone (estrogen and progesterone) metabo-
lites in urine. Hormone metabolite analysis of
the paper-stored samples was comparable to
results obtained from analyses of the original
liquid samples. Furthermore, storage of up to
1 year had no effect on hormone concentra-
tions. This technology may also lend itself to
the analysis of many other metabolites, includ-
ing those derived from pesticides, drugs, and
other toxicants. For example, McCann et al.
(1995) quantified orotic acid (vitamin B13)
from such samples. Despite these ﬁndings, it is
clear that further pilot studies examining the
optimal filter paper to use and the range of
metabolites that can be detected need to be
carried out before this method of storing and
shipping home-collected specimens can be
considered more seriously.
Collection of urine from infants, potentially
one of the most highly sampled subgroups in a
children’s longitudinal study, offers a unique
challenge. Several approaches have been used,
including collection pads (placed inside diaper),
U-bags, and clean catch into sterile bottles. A
study by Liaw et al. (2000) found that all
approaches were equally effective at excluding
infection and avoiding contamination of
samples. However, parents preferred collection
pads because they were easier to use and most
comfortable for the infant. Robertson and
Fortmann (Unpublished data) are attempting
to simplify the process even further by develop-
ing a system for extracting urine from dispos-
able diapers and analyzing it for biomarkers of
pesticide exposure and creatinine. 
Collection of samples from toilet-trained
children (approximately 2–5 years of age) is
less challenging, though special measures may
still be needed. For example, in a study of
organophosphorous pesticide exposure by Curl
et al. (2003), parents were provided with a
commode specimen collection pan and
polypropylene bottles to store the samples.
Children urinated either into the commode
inserts, the contents of which were then
poured into a polypropylene bottle, or directly
into the bottles. Urine collection bottles were
stored inside the plastic container in the fami-
lies’ refrigerators overnight until researchers
retrieved them the following day. 
Blood. What can be measured in blood?
Blood is a relatively accessible and informative
tissue, although its collection is somewhat
invasive and many study participants refuse to
donate blood specimens for research pur-
poses. Numerous naturally occurring bio-
chemical molecules can be found in blood,
including hormones, various other proteins,
and chemical metabolites. Environmental
pollutants such as organochlorine compounds
(Mussalo-Rauhamaa 1991), dioxins (Smith
et al. 1992), polychlorinated biphenyls (PCBs)
(Schuhmacher et al. 2002), hexachloro-
benzene, and 1,1-dichloro-2,2-bis(p-chloro-
phenyl)ethylene (p,p´-DDE) (Becker et al.
2002) can also be measured in blood. Metals
such as beryllium, cadmium, manganese,
mercury, and lead (Becker et al. 2002;
Schuhmacher et al. 2002), and drugs such as
nicotine (or its metabolite cotinine), cocaine,
and caffeine (Dempsey et al. 1998) can be
measured in blood as well. Nucleated cells (pri-
marily leukocytes) can be obtained from blood.
These are useful in that they can be cultured
ex vivo to examine how they respond to various
cytokine and chemical exposures, which may
give some idea how the individual would
respond if exposed to the same. Leukocytes can
also provide RNA for gene expression analysis
(Rockett et al. 2002) and DNA, which can be
used for polymorphism and sequencing analy-
sis and to detect chromosomal aberrations
(Sorokine-Durm et al. 1997) and DNA adduct
formation (Poirier 1997).
How can collection of blood be
conducted in the home environment? Proper
extraction, handling, and transportation pro-
cedures are most important in blood collec-
tion to prevent injury to the donor, protect
the collector from accidental exposure to
infectious microbes, and maintain specimen
integrity. With few exceptions, the home col-
lection of blood requires the presence of a
trained phlebotomist. Even so, if a blood draw
is prepared and transported under improper
conditions, laboratory test results can be
altered. A recent review by Becan-McBride
(2002) examines in detail how samples col-
lected in nonclinical environments such as the
home should be transported to avoid specimen
transportation errors. Depending on the ana-
lyte(s) to be measured, the blood may need to
be kept within a certain temperature range. It
is also necessary to use appropriate collection
tubes. A variety of tubes are available from sev-
eral suppliers. Different additives are included
in the tubes depending on what the sample
will be used for. For example, sodium heparin
and sodium–EDTA tubes are generally used
where trace element, toxicology, and nutri-
tional analyses will be conducted. Potassium
oxalate/sodium ﬂuoride tubes are used for glu-
cose determinations. Tubes containing clot
activators and gel are used for preparing serum
for hormone and other analyses. For further
details see the BD Vacutainer tube guide
(Becton, Dickinson and Company 2003).
Other tubes are available (PaxGene blood col-
lection tubes; Qiagen Inc., Valencia, CA;
http://www1.qiagen.com/default.aspx) whose
contents “freeze” cell transcription and preserve
RNA for gene expression studies, though these
are currently approved for research use only. 
In most cases, unnecessary shaking must be
avoided to prevent hemolysis, and samples
must sometimes be returned to the analysis
laboratory within a strict time frame to permit
certain assays to be performed.
Blood is transported in a collection tube.
However, as with urine, studies determining
the value of collection and transportation of
blood specimens on filter paper have been
conducted. The idea of collecting blood sam-
ples on ﬁlter paper has been around for more
than 30 years (Hill and Palmer 1969). Parkes
et al. (1999) recently reported an at-home test
that combined a filter paper technique for
spotting capillary blood with an immuno-
turbidometric assay for measuring hemoglobin
A1c. Others have successfully used a similar
approach to measure glucose (Ward et al.
1996) and HIV infection (Spielberg et al.
2000), and these discoveries have prompted
the commercial development of home collec-
tion kits. At least two companies currently
market products for consumers to check their
HIV status. Both kits require the individual to
collect a small blood sample from her/his
ﬁngertip and mail it to a designated medical
laboratory for analysis. Study data seem to
support the accuracy and reliability of HIV
testing through at-home collection, demon-
strating 99.9% accuracy.
Other companies (e.g., FlexSite Diagnostic
Inc., Palm City, FL; http://www.ﬂexsite.com/
pgs/3.html) specialize in the development of
products and services that allow complex diag-
nostic tests to be conducted in the home and
other nonlaboratory settings. A FlexSite prod-
uct near release is a cholesterol proﬁle kit that
uses a patented device to collect a dried blood
sample for measuring total cholesterol, high-
density lipoprotein cholesterol, and tri-
glycerides, along with a computed low-density
lipoprotein cholesterol. The device (SerSite)
separates serum from blood cells as it absorbs
the blood. The blood sample is then mailed in
a dry state to the FlexSite clinical laboratory for
analysis. Although such kits exist or are under
development, they are marketed primarily to
medical workers who take patient samples out-
side the clinical environment and thus are not
designed for use by the general public. 
Home collection of blood is a limited
option for large studies for the following
reasons:
• Most important, obtaining reasonable quan-
tities of blood (a few milliliters) via a venous
puncture is a somewhat invasive procedure
with possible adverse side effects if carried
out incorrectly. As such, it requires the
supervision or assistance of a trained phle-
botomist.
• Although small amounts of blood can be
obtained by finger prick, many people are
reluctant about lancing their fingers or are
hesitant about the sight of their own blood.
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children and parents are sometimes reluctant
to approve the procedure.
• Many potentially useful analytes in blood
are labile and samples require either imme-
diate processing or a controlled storage of
the type not normally found in the home.
Thus, although blood is one of the most
useful of biospecimens on which a variety and
types of assays can be conducted, home
collection may not be feasible for a large epi-
demiologic study that relies on study partici-
pants alone for the collection of blood.
Perhaps the only exceptions to this are certain
groups of individuals (e.g., diabetics, nurses)
who are trained and/or are familiar with tak-
ing small samples of their own blood. Such
people may provide good cohorts for blood-
based subsampling studies.
Semen. What can be measured in semen?
Of late, semen collection is receiving increasing
attention with respect to home collection.
Semen can be analyzed to evaluate sperm char-
acteristics and to measure hundreds of biologi-
cal and chemical components of seminal ﬂuid
including steroid hormones, sugars, vitamins,
enzymes, proteins, and metals. In addition,
environmental exposures can introduce xeno-
biotic compounds such as pesticides and heavy
metals into seminal ﬂuid (Kumar et al. 2000).
This has two possible ramifications. First,
many kinds of exposures and chemicals affect
human sperm quantity and quality. Second,
the vagina absorbs a number of components of
semen that can be detected in the female
bloodstream within a few hours of sexual inter-
course (Benziger and Edelson 1983; Sandberg
et al. 1968). This has possible implications for
the exposure of embryos and fetuses to compo-
nents of seminal ﬂuid by both intracanicular
and bloodborne routes and may even serve as a
route of exposure for women.
Many xenobiotics, metals, and naturally
occurring biochemical components of semen
have been measured to determine how their
presence relates to fertility (Lay et al. 2001;
Younglai et al. 2002). In addition to measur-
ing biochemical components of the semen,
one can conduct routine sperm analysis (con-
centration, motility, morphology) (Davis and
Katz 1989; WHO 1999), evaluate more spe-
ciﬁc markers of sperm function such as genetic
and chromosome integrity (Evenson et al.
2002; Perreault et al. 2000), and conduct gene
expression proﬁling experiments (Ostermeier
et al. 2002).
How can collection of semen be con-
ducted in the home environment? Various
investigators have developed prototype collec-
tion and transportation kits, such as the
TRANSMEM100 (Royster et al. 2000).
These kits can be distributed to study partici-
pants, and then collected by the study person-
nel, delivered by the participant, or shipped
directly to a central laboratory for analysis
once the sample has been collected. The
TRANSMEM100 collection system was
intentionally made simple, requiring only that
the subject collect the semen sample in a toxi-
cology-tested specimen jar, place the jar in a
biohazard bag and secondary container, close
the package, and call the overnight courier for
pickup. Illustrated instructions are included
with the kit. The initial pilot study on the util-
ity of the TRANSMEM100 indicated that
65–80% of the samples were received in the
laboratory the day after they had been col-
lected and were of sufﬁciently good quality to
carry out a number of standard measurements
such as semen volume, and sperm number,
concentration, and morphology.
Recently, the TRANSMEM100 was tested
for sample stability with regard to newer, more
specific tests of sperm nuclear integrity. For
example, the sperm chromatin structure assay
(SCSA; SCSA Diagnostics, Inc., Brookings,
SD; http://www.scsadiagnostics.com/) detects
increased susceptibility to acid-induced DNA
damage in sperm and is a measure of sperm
genomic integrity (Evenson et al. 2002). SCSA
results were comparable when semen samples
were frozen right after collection or after 24-hr
storage at 4°C, but the percentage of abnormal
cells increased signiﬁcantly if samples were kept
at room temperature for the 24 hr before freez-
ing (Morris et al. 2003). These ﬁndings indi-
cate that inclusion of cold packs during
overnight shipment would be necessary to
ensure sample stability for this assay. On the
other hand, an assay measuring chromosome
breakage in sperm gave comparable results in
fresh semen and semen stored at room
temperature for 24 hr (Young et al. 2003). 
Other approaches range from the rela-
tively advanced Bio-Tranz (Zavos Diagnostic
Laboratories, Inc., Lexington, KY; http://
www.zdlinc.com/index.htm) shipping system
(Zavos et al. 1998), for shipping semen at low
temperature in protective medium to allow
clinical diagnosis of infertility, to a simple
process in which semen was frozen in con-
doms by study participants and later collected
by the study organizers (Arbuckle et al.
1999). Although such simpliﬁed storage and
collection procedures reduce the number of
fecundity markers that can be measured in
fresh, whole semen, they can still be used to
measure the presence of pesticide metabolites
and other stable biochemical molecules.
Although none of these home-collection
systems have been thoroughly characterized for
their ability to maintain the integrity of all the
numerous analytes that can be measured in
semen, they have clearly proven useful for
measuring a number of useful parameters (e.g.,
certain sperm measures and pesticide levels).
There is clearly a trade-off between the cost
and complexity of the transportation system
and the number of end points that can be
measured in the laboratory. These considera-
tions will need to be weighed in relation to
study purpose to determine their ultimate
applicability for ﬁeld-based research.
Other Potential Biospecimens
for Home Collection
Biospecimens with the potential for home col-
lection need to be informative, accessible, and
easy to produce. Saliva, milk, hair, hair folli-
cles, nail, and buccal cells may also prove to be
viable alternatives, depending on the biological
marker being measured, and have been used
with varying degrees of success.
Saliva. Steroid hormones normally are
measured in urine and blood. However, several
can also be measured in saliva, including
dehydroepiandrosterone (DHEA), dihy-
drotestosterone, testosterone, estradiol, estrone,
progesterone, and androstenedione cortisol.
The use of saliva as a biospecimen offers several
advantages:
• Ease of use: Saliva specimens can be collected
anywhere at any time and at a much lower
cost than blood collection. For example, col-
lection of saliva samples from highly mobile
ﬂight attendants also was reported to produce
high-quality samples for analysis (Whelan
et al. 2002).
• Saliva collection is noninvasive and less stress-
ful than venipuncture and thereby less likely
to alter markers responsive to physiologic/
psychologic stress.
• Saliva collection is more feasible when collec-
tion at timed intervals is desired (e.g., early
morning).
• Hormones in saliva are exceptionally stable.
They can be stored at room temperature for
at least a week without loss of activity. 
The choice of a saliva collection method
should be tailored to the individual hormones
to be quantified, as studies have shown that
certain types of collection methods, such as
the cotton-based Salivette system (Sarstedt,
Newton, NC; http://www.sarstedt.com/php/
main.php?SID=c1a82144d94e2efe0f11ec7ba7
4b3f72&language=en), can produce artiﬁcially
elevated levels of certain hormones, including
DHEA, testosterone, and estradiol (Granger
et al. 1999a, 1999b; Shirtcliff et al. 2000,
2001). With this in mind, several methods are
available currently for home collection of
saliva. The ﬁrst is to request study participants
to expectorate up to 3 mL of saliva into a
wide-mouthed container over a period of
10 min (Riad-Fahmy et al. 1987). The second
is to ask participants to chew on a 6-inch cot-
ton dental roll (Hertsgaard 1992). A portion
of the saturated roll is subsequently placed
into a needleless syringe and the saliva
expressed into vials for analysis. The most
common method, however, is to use the com-
mercially available Salivette collection system.
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polyester roll for 3 min before placing it into a
plastic tube for shipping and analysis. Once
the sample arrives at the laboratory, the tube is
centrifuged to recover the saliva. Although
three different versions of the Salivette system
are available, studies have shown that the poly-
ester insert form without citric acid crystals is
generally the most appropriate for research
purposes (Lamey and Nolan 1994; Schwartz
et al. 1998), as the use of citric acid crystals to
stimulate saliva ﬂow can interfere with certain
assays by lowering the pH of the sample
(Schwartz et al. 1998). Salivette samples will
begin to mold after 4–7 days; thus, it is rec-
ommended that they be stored at –20°C, if
possible. Samples can later be shipped (on dry
ice) to the testing facility via regular mail. 
Of course there are also limitations to
using saliva. The number of hormones that can
be measured in saliva is fewer than can be
measured in blood, and unlike blood, saliva
does not provide live cells for other types of
studies such as RNA expression analysis.
Breast milk. Research on chemical conta-
minants in breast milk spans several decades
and dozens of countries. Results indicate that a
wide range of chemical contaminants may
enter breast milk, including organochlorine
pesticides, PCBs, polychlorinated dibenzo-
p-dioxins (PCDDs), polybrominated diphenyl
ethers, metals, and solvents (Solomon and
Weiss 2002). These ﬁndings have highlighted
gaps in current knowledge about this postnatal
route of exposure, including the lack of infor-
mation on the nature and levels of contami-
nants in breast milk and the lack of consistent
protocols for collecting and analyzing breast
milk samples. Breast milk contaminants are of
particular interest where breast-fed infants are
concerned, as many of the contaminants iden-
tified thus far have developmental effects in
rodent models. Developmental effects in
humans are not well characterized, and there is
a general lack of data on health outcomes that
may be produced in infants by exposure to
chemicals in breast milk. However, in the
studies conducted thus far, there is evidence
that exposure to PCBs both pre- and postna-
tally through breast milk does have subtle neg-
ative effects on neurologic and cognitive
development of children up to school age
(Vreugdenhil et al. 2002; Walkowiak et al.
2001). Reproductive effects may also occur.
For example, Blanck et al. (2000) found that
in utero and lactational exposures to poly-
brominated biphenyls were associated with an
earlier age of menarche.
Despite such studies, there remains a
general paucity of data on outcomes related to
infant exposure via breast-feeding, particularly
those with a time-dependent nature. This
information is necessary for performing expo-
sure assessments without heavy reliance on
default assumptions. Landrigan et al. (2002)
thus called for “a carefully planned and con-
ducted national breast milk monitoring effort
in the United States” to provide the informa-
tion needed to assess infant exposures
through breast-feeding and to develop scien-
tifically sound information on the benefits
and risks thereof.
Collection of milk in the home environ-
ment for contaminant analysis is relatively sim-
ple. In a recently completed prospective
pregnancy study that recruited women from
16 counties upon stopping birth control,
women who later gave birth and initiated breast
feeding were asked to provide at least one breast
milk sample using a standardized protocol
(100% compliance). Mothers successfully col-
lected and shipped fresh milk samples along
with a freezer pack to a toxicologic laboratory
via Federal Express (Buck et al. 2002). Frozen
breast milk samples have been used to analyze
levels of PCBs, PCDDs, polychlorinated
dibenzofurans, and numerous organochlorine-
based compounds (Hooper et al. 2002).
Further information on the collection and
archiving of human milk may soon become
available from the U.K. Department for
Environment, Food and Rural Affairs. The
department is currently cofunding a pilot pro-
ject for establishing a U.K. human milk archive
of representative samples that will be available
for chemical analysis for up to 10 years (H.M.
Government Department for Environment,
Food and Rural Affairs 2002). The study aims
to develop methods for recruiting participants,
establish robust procedures for collection, trans-
port, storage, and analysis of breast milk, and
perform initial analysis for PCBs, dioxins, and
phytoestrogens. Data from this study will pro-
vide information on temporal trends of envi-
ronmental contaminants and an assessment of
infant risk from exposure via human milk.
Hair/nail. The main advantage of using
hair and nail is that is that they can be col-
lected in a safe and noninvasive manner.
However, being keratinous in nature and con-
taining no living cells, hair and nail are not
often considered of high value for many epi-
demiologic and exposure studies. Nevertheless,
they may be useful biospecimens under certain
circumstances. Hair, for example, has been
used for decades as a timeline for exposure to
heavy metals. Many heavy metals impact fer-
tility and fecundity, either through direct toxi-
city in the reproductive organs, adversely
affecting the endocrine system, or both. Lead,
chromium, and cadmium, for example, reduce
human semen quality (Li et al. 2001; Telisman
et al. 2000). Female exposure to mercury alters
estrous cyclicity in rats (Davis et al. 2001), and
recently, blood lead levels were negatively asso-
ciated with puberty milestones in girls (Selevan
et al. 2003; Wu et al. 2003). Hair analysis can
indicate exposure to numerous toxic metals
including mercury, lead, arsenic, aluminum,
and cadmium, and numerous other metals
including calcium, zinc, manganese, cobalt,
iron, potassium, sodium, and titanium.
Although a useful tool for detecting chronic
exposures, hair is not suitable for detecting very
recent metal exposures (a blood test is required
for this).
The clipping, storage, and transportation of
nail and hair is clearly a simple task that can be
conducted by most individuals. If the hair is
long enough, it is generally taken from the nape
of the neck. About an inch in length of the hair
closest to the skin is needed in a quantity
approximating a heaped teaspoon full. For bald
men or those reluctant to donate head hair, a
viable alternative is to take samples from the
under arm or pubic area.
A little-tested use of hair and nail is gene
sequencing. Mitochondrial (mt)DNA can be
found in hair and nail (Anderson et al. 1999;
Schreiber et al. 1988). Some groups have suc-
cessfully tested hair and nail as an alternative
to blood DNA for genotyping of polymor-
phic drug-metabolizing enzymes (Tanigawara
et al. 2001).
One possible disadvantage of using hair
and nail is that they can be easily contaminated
with extraneous biological and chemical mater-
ial (e.g., dirt under the nails; shampoo and dye
residues in hair) that can sometimes complicate
tissue analysis. Hair chemicals, including dyes,
can contain lead that will attach to the hair and
may contaminate the sample. The most accu-
rate results thus come from hair that has not
been chemically treated for at least 2 months.
Hair follicles. An aggressive pluck of a
human hair will usually remove the root follicle
along with the hair. In about 90% of cases, this
specimen (trichogram) will be of a hair in the
actively growing phase (anaphase), and there-
fore likely to yield sufﬁcient quantities of good-
quality RNA to support gene expression
analysis. RNA is notoriously quick to degrade
in samples once they are detached from a body.
Therefore, to maintain the integrity of the
RNA, such samples normally need to be
processed quickly. Ambion, Inc. (Austin, TX;
http://www.ambion.com/) has recently devel-
oped a storage product called RNALater, an
aqueous, nontoxic tissue storage reagent that
rapidly permeates tissues to stabilize and pro-
tect cellular RNA (Ambion 2003). Once in
RNALater, RNA is stable for 1 week at room
temperature, 1 month at 4°C, or indeﬁnitely if
frozen. These properties could be used to
develop a simple kit that permits the home col-
lection, storage, and shipping of hair follicles
without specialized protocols or equipment.
Previous studies have found the yield of
RNA from such human hair follicles to be in
the region of 0.9 µg per whole follicle (Mitsui
et al. 1997). This is sufﬁcient for small numbers
of limited gene expression profiling analyses
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RT-PCR–based gene expression profiling
carried out on RNA extracted from hair follicles
has yielded information on gene expression of
growth factors (Mitsui et al. 1997) and
enzymes (Chang et al. 1997). Unfortunately,
RT-PCR assays are a rather limited form
of gene expression analysis in that they can
measure expression of only a few genes at a
time. The recent development of DNA arrays
(see reviews by Rockett and Dix 1999, 2000)
has overcome this problem. Such arrays can
detect the expression of many tens of thou-
sands of genes simultaneously. Unfortunately,
most require more RNA than can be obtained
from a few hair follicles. The solution may be
to incorporate a preampliﬁcation step prior to
labeling and hybridization of the RNA sam-
ple. Fink et al. (2002) used this approach suc-
cessfully in carrying out microarray analysis of
RNA extracted from laser capture microdis-
section samples. Although the parity between
array data from preamplified and regular
RNA samples has yet to be fully established,
early indications are that the gene expression
patterns are fairly comparable. Alternatively,
rolling circle amplification of the bound
probe following hybridization to the microar-
ray (Nallur et al. 2001) may prove a viable
alternative.
In the future such studies using RT-PCR
or gene array analysis may provide information
on exposures through the identiﬁcation of cer-
tain gene expression patterns. However, this
approach is currently in embryonic form and
will probably be without practical application
for 5–10 years.
Buccal cells. Perhaps the most useful appli-
cation of buccal cells (the epithelial cells lining
the inside of the cheeks) is as a source of DNA
for genotyping studies. However, buccal cells
have also been used as a source of material for
immunoassays (Byrne et al. 2000) and appear
to be a good source of tissue for monitoring
human exposure to inhaled and ingested occu-
pational and environmental genotoxicants.
Results of a study by Burgaz et al. (2002) sug-
gested that occupational exposure to organic
solvents may cause cytogenetic damage in buc-
cal cells and that use of exfoliated buccal cells
appears appropriate to measure exposure to
organic solvents.
These studies together demonstrate how
the same samples can sometimes be used to
measure markers of both exposure and effect,
thus helping to maximize the amount of useful
information that can be obtained from a
sample and improving the cost-beneﬁt ratio.
Exfoliated buccal cells can be collected
quickly, easily, and conveniently. Several
methods of collection have been described,
including the use of special cards (Harty et al.
2000a), cytobrushes (Garcia-Closas et al.
2001), cotton swabs (Koletzko et al. 1999),
saline rinses (Hayney et al. 1995), and mouth-
wash. Lench et al. (1988) originally demon-
strated that sufficient human DNA for gene
analysis can be isolated from buccal cells
obtained by mouthwash. Lum and Marchand
(1998) later confirmed this, showing that
good-quality DNA suitable for PCR-based
genotyping could be obtained from 10 mL
undiluted commercial mouthwash swilled in
the mouth for 60 sec, then expelled into a
collection container.
For home collection of buccal cells (at least
for DNA analysis purposes), the aforemen-
tioned studies and others have shown that col-
lection using the mouthwash approach gives
greater yields than other methods and is feasi-
ble for use in cohort studies. Lum and
Marchand (1998) reported that storage of the
unprocessed specimens at room temperature or
at 37°C for 1 week (temperature conditions
that may be encountered when mailing sam-
ples) did not affect the DNA yield or ability to
PCR amplify the samples. Study workers for
the National Birth Defects Prevention Study
(2003) have successfully developed and used
kits for the collection of buccal cells, which are
sent to study participants through the mail
(Rasmussen et al. 2002). The kit contains an
informed consent form, simple instructions,
materials for collecting the specimens, a small
monetary reimbursement in the form of a
money order, and a prepaid U.S. Mail packet
for specimen return.
The main caveat of using buccal cells for
DNA is that researchers should be aware of the
likely presence of nonhuman DNA in the
extracted specimens. This can originate from
food residues and from microﬂora that live in
the digestive system and respiratory tract. Such
nonhuman DNA is normally not problematic
for PCR and other hybridization studies as
long as appropriate (i.e., speciﬁc) probes and
primers are selected.
Vaginal swabs. Bacterial vaginosis (BV) is
an alteration of the vaginal ﬂora where the nor-
mally predominant Lactobacilli are replaced by
a cocktail of other organisms, including those
responsible for sexually transmitted diseases
(STDs) (e.g., Neisseria gonorrhoeae, Chlamydia
trachomatis, and Trichomonas vaginalis). BV
has been associated with a number of adverse
outcomes in pregnant women, including late
miscarriage, premature rupture of membranes,
preterm delivery, postpartum sepsis and post-
partum endometriosis (Gravett et al. 1986;
Hay et al. 1994; Jacobsson et al. 2002).
Prevalence of BV varies among different
groups of women, but recent studies suggest
that between 4 and 61% may suffer from the
disease, including as many as 20% of pregnant
women and 12% of adolescent virgins
(Priestley and Kinghorn 1996). 
The diagnosis of BV normally requires the
procurement of vaginal swabs. These can be
used to identify agents of infection through
microscopic observation, microbial culture, or
nucleic acid ampliﬁcation technologies. There
is evidence to suggest that collection of vaginal
swabs may be amenable to home-based strate-
gies and have the added beneﬁt of increasing
participation. In an office-based study by
Smith et al. (2001), participants were offered
the choice of STD screening in the context of
a traditional pelvic examination or the use of
self-obtained vaginal swabs. All eligible partici-
pants chose the latter, suggesting that most
female patients are comfortable obtaining such
samples. In a different approach, clinical staff
were successful in visiting the homes of com-
munity-based trial participants and collecting
self-administered vaginal swabs (Wawer et al.
1998). Compliance with interview, sample
collection, and treatment in this study was
over 90%. 
The home collection of vaginal swabs
raises two issues. The ﬁrst is the potential bio-
hazard issue to other family members or visi-
tors, although this could conceivably be
overcome by the use of carefully designed con-
tainers. The second is that storage of samples
or delay in getting them to the laboratory may
adversely impact identification of infectious
agents using standard microscopic or culture
techniques. An appropriate method for the
collection, storage, and transportation of self-
administered vaginal swabs thus needs to be
determined. Alternatively, nucleic acid ampli-
fication methods are available (Smith et al.
2001) that are both sensitive and adaptable to
high-throughput assays.
Home-Based Analysis 
of Biospecimens
Recent increases in technology now permit
participants to not only collect biospecimens
at home, but also analyze them. Using
commercially available kits, individuals are
now able to track the timing of their fertile
window, identify pregnancies, and estimate
sperm concentrations in semen, all in the pri-
vacy of their own home. These new tech-
niques offer promise for research purposes, as
they allow investigators to collect information
without the time and cost associated with hav-
ing samples analyzed at a remote location.
Home fertility monitors. Home fertility
monitors are now available that allow women
to detect both the occurrence and timing of
ovulation. Several kits are commercially avail-
able, including ClearPlan Easy (Unipath Ltd.,
Bedford, Bedfordshire, UK; http://www.uni-
path.com), Ovuquick One-Step (Quidel
Corp., San Diego, CA; http://www.quidel.
com/Home.php), and Surestep (Applied
Biotech, Inc., San Diego, CA; http://
www.abiapogent.com). The kits work by
detecting the LH surge in urine with varying
levels of sensitivity, ranging from 35 mIU/mL
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(Nielsen et al. 2001). The ClearPlan Easy kit
offers an advantage over the other methods in
that the system will store basic fertility data
for up to 6 months. The information is stored
on a data card that can be easily transported
to the study site for download to a personal
computer. The information stored includes
the start date of each cycle, the cycle length,
the date the LH surge, and the dates of inter-
course. Other home-based ovulation detec-
tion systems, such as the Lady Free Biotester
(TK Yun, South Korea) and the TCI
OvuLook (TCI Optics, Inc., Kapaau, HI;
http://www.ovulook.com/), detect ovulation
based on salivary ferning (Barbato et al.
1993). The latter also has a built-in tracking
system that allows women to see and refer
back to their saliva patterns over time, thus
providing a system that could be useful in
epidemiologic studies.
Home pregnancy tests. In 1999 approxi-
mately 19 million home pregnancy test kits
were sold in the United States (Lipsitz 2000).
Among a sample of women with children,
approximately 33% reported using a home
pregnancy test prior to seeking care from a
professional (Jeng et al. 1991). The currently
available home pregnancy test kits use mono-
clonal antibodies to detect hCG in urine.
Although the manufacturers of home
pregnancy test kits claim that they are
97–99.5% accurate, recent work suggests
that the individual sensitivities and speciﬁci-
ties vary somewhat by brand when the prod-
ucts are used in the general population
(Bastian et al. 1998). Many kits instruct
women to test their urine as early as the day
that menses is expected. However, using
women’s self-reported average cycle lengths,
Wilcox et al. (2001) estimated that the maxi-
mum possible sensitivity on the day that
menses is expected is 90%. Only after 1 week
was the sensitivity found to be about 97%.
The high false-negative rate seen among
home pregnancy tests has been attributed to
two factors. Without the aid of a fertility
monitor to pinpoint ovulation, women who
ovulate late in their cycle may end up testing
too early (i.e., before implantation has had
time to occur). Comprehension of testing
protocols needs to be established to ensure
that study participants are using kits correctly
and yielding valid data. We are aware of only
one study that reported difﬁculties associated
with understanding the instructions in home
pregnancy tests. In this study Daviaud et al.
(1993) reported that 230 of 478 positive
pregnancy tests were falsely interpreted as
negative, with difﬁculty in understanding the
directions being cited as the primary reason
for the error.
Although there may be some concern
that home pregnancy tests are marketed to the
general public as being highly sensitive and
specific throughout testing, they remain an
extremely valuable data collection methodol-
ogy in a research setting. Home pregnancy test
kits allow investigators to detect early losses in
situations where the collection of urine for
analysis at a remote location is not feasible.
Through careful instruction, women can be
shown how to use the kits in a manner that
reduces the chances of generating false data.
At-home screening for male infertility.
Recently, an at-home test kit became available
(FertilMarQ; Embryotech, Wilmington, MA;
http://www.embryotech.com) that allows men
to evaluate one aspect of semen quality, sperm
concentration, in the privacy of their home.
According to the instructions, semen samples
are to be collected by either masturbation or
intercourse (with a special condom) following
a 3-day period of abstinence. After allowing the
semen to liquefy in the provided cup for at
least 15 min, it is transferred to the testing well
via dropper and combined with the appropri-
ate reagents. A light blue color in the test well
indicates that the individual has a sperm con-
centration of < 20 million/mL, which is consis-
tent with the operational definition for
oligospermia (Rowe et al. 1993). The test is to
be repeated 3–7 days after the ﬁrst test to con-
firm the finding. According to the manufac-
turer, the overall accuracy of the test is 78%.
Although the test cannot provide a deﬁnitive
answer regarding the presence of male infertil-
ity, it may serve as a useful screening tool in
certain populations.
Limitations of Home-Based
Collection and Analysis 
of Biospecimens
Noncompliance. In many cases, home collec-
tion of specimens may seem to be an ideal
solution to some of the limitations of clinic-
based studies. However, it is not without its
potential problems. Although the conve-
nience factor may be an important considera-
tion, it is prudent to recognize that the
advantages of home-based sample collection
are potentially offset by noncompliance with
collection and storage instructions. For exam-
ple, with respect to many sensitive reproduc-
tive end points such as hormonal proﬁles, the
need for specimen collection timed to a men-
strual cycle or to accommodate diurnal or
other fluctuations can be more difficult
(though not impossible) to capture success-
fully in the home. 
Range of assays. Many potentially useful
assays and experiments cannot be conducted
on biospecimens collected and stored in the
home. Home collection clearly lacks the clini-
cal and/or scientiﬁc environment (i.e., equip-
ment and specialized training) necessary to
collect and process certain analytes. For exam-
ple, if live cells are needed (e.g., blood cells for
in vitro exposures or semen for sperm motility
measures), the samples need to be collected in
an environment where they can be processed
quickly before the cells die. 
Introduction of error. A further complicat-
ing factor is that many laboratory and health-
care workers overlook the impact of specimen
collection, storage, and transportation on med-
ical errors. Specimen collection and transporta-
tion originating outside the laboratory can
increase laboratory error rates. Indeed,
46–68% of laboratory errors occur in the pre-
analytical rather than in the analytical and
postanalytical phases (Boone et al. 1995;
Plebani and Carraro 1997). Thus, when plan-
ning an epidemiologic study involving the col-
lection of field specimens, the nature of the
specimens and the types of measurements that
will be derived from them must be carefully
considered to determine the best way to
obtain, store, and transport the specimens to
maintain the integrity of the target parameters
(e.g., steroid hormones, pesticide metabolites,
DNA, RNA).
Transportation of biospecimens. Move-
ment of samples from the homes of study par-
ticipants to the clinic or analytical laboratory is
perhaps the main factor when considering the
suitability of home collection, as it usually
involves the most time and expense and
increases biohazard concerns. Transportation
can take place via one of three modes:
• Conveyance to the clinical ofﬁce by the study
participant. Again, transportation is normally
at ambient temperature. This approach may
reduce costs slightly, facilitate more rapid
transfer of the sample, and reduce the
chances of the sample being lost or damaged
in transit.
• Collection by study staff. This may facilitate
maintenance of samples in a more controlled
environment (e.g., frozen) but is more costly
than the other two methods.
• Shipping by mail or courier service. In most
cases, samples are shipped at ambient temper-
ature. This is acceptable for many analytes.
Where necessary (usually in warmer climates),
cold packs can be included to maintain a cool
temperature during overnight shipments and
avoid sample degradation. However, when
time is a critical factor (e.g., sperm motility as
a part of semen analysis), a courier may be the
only (and more costly) alternative. 
In terms of biohazard risk, the main
pathogens of concern are bloodborne
pathogens such as HIV and hepatitis.
However, the handlers of any human biospec-
imens can be at risk of exposure to these or
other pathogens. The risk is minimized when
the patient brings samples into the clinic.
Risk is increased for study workers who visit
the subject’s home to obtain the sample (e.g.,
draw blood) and transport it. In these cases
the safety of the study worker and participant
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validated stepwise procedures designed to
reduce the chances of sample exposure. The
collection of liquid samples presents the great-
est risk to those who collect and transport
them, and there should be established proto-
cols for carrying equipment and samples. For
example, all equipment and samples should
be transported in a sturdy lockable container
with specimens inside sealed in a secondary
container displaying a biohazard label. 
The risk of accidental exposure becomes
higher when biological samples, particularly in
liquid form, are shipped via courier or postal
service. Indeed, biological specimens should
not be sent by courier or through the mail
unless they are contained in an approved ship-
ping container. In the United States, this
means that the containers must comply with
U.S. Postal Service regulations (USPS 1999),
Centers for Disease Control and Prevention
regulation 42 CFR72 (CDC 1999), and
Department of Transportation regulation
67 FR 53118 (DOT 2002), all of which
address the shipment of clinical specimens.
Various companies produce such containers.
Doxtech (Beaverton, OR; http://www.dox-
tech.com/), for example, produces a high secu-
rity container for collection, transport and
storage of specimens for “drug testing, forensic
evidence, food samples and potable water sam-
ples.” Quorpak (Bridgeville, PA;
http://www.qorpak.com/) produces a two-part
specimen mailer manufactured to meet govern-
ment regulations for mailing liquids in glass or
plastic. The outer container has a ﬁberboard
body with a waxed inside liner, and the metal
neck is securely crimped to the ﬁber body. The
inner container, which holds the specimen, is a
high-density polyethylene bottle with a
polypropylene closure and polyethylene foam
liner. The increasing number of biospecimens
being sent through the mail has even prompted
some postal agencies to design special single-
use containers specifically for this purpose.
The Royal Mail Service in the United
Kingdom recently launched Safebox, a prepaid
packaging concept for medical, veterinary, and
pharmaceutical samples (First Filtration
International,  Banglamung, Thailand;
http://www.ﬁrstﬁltration.com/safebox.html).
Safebox is a tough plastic container that is
delivered by the Royal Mail as part of a normal
postal delivery. It is opened at the laboratory
by pulling off a tear strip and because the inner
chamber is transparent, any leakage can be
detected without risk of physical contact. If
leakage does occur, it is absorbed by the Aqui-
Pak system (First Filtration International), a
protective packaging material for the transport
of pathological specimens. Aqui-Pak complies
fully with secondary packaging instructions
issued by the USPS and Royal Mail. Finally,
because the Safebox is designed for single use
only, there is no risk of cross-contamination
from packaging materials being reused. 
In some cases ﬁeld specimens may be origi-
nate outside the country where the analytical
laboratory is based. Since the World Trade
Center tragedy, the international transportation
of hazardous or potentially hazardous agents
has come under increased scrutiny. Given that
all human samples are considered potentially
hazardous, investigators are responsible for
adhering to packaging and shipping standards
issued by the International Air Transport
Association (IATA). The IATA produces both
regulation and training literature for dangerous
goods, and various IATA-endorsed training
programs are offered by companies specializing
in the provision of such training.
Conclusions
Though there are a number of caveats, the use
of home-based collection of biospecimens in
epidemiologic studies, including those focusing
on sensitive reproductive end points, should
assist investigators in obtaining high participa-
tion rates and thereby minimize misclassiﬁca-
tion bias regarding either exposure or effect.
This strategy, in addition to all the other advan-
tages discussed, helps to ensure valid study con-
clusions while filling critical data gaps. For
example, couple-based prospective pregnancy
studies designed to assess effects of parentally
mediated exposures before, at, or shortly after
conception could benefit from home-based
biospecimen collection, which would make it
easier to obtain samples at speciﬁc times over
the course of menstrual cycles, pregnancy, and
lactation. Such approaches offer promise for
ascertaining data to ﬁll critical data gaps such as
the toxicokinetics of environmental contami-
nants across pregnancy and lactation as well as
their effects, if any, on sensitive markers of
human reproduction and development.
Urine and blood continue to lead the way
as the most popular biospecimens obtained in
epidemiologic studies. This is mainly because
they are both accessible and informative for a
large number of clinically important parame-
ters. The methodology for collecting, storing,
and transporting these types of sample is also
well established for measuring a number of
parameters. Urine particularly appears to offer
a good way forward, as it is relatively easy to
collect from all age groups, and for many ana-
lytes the sample can be stored from room
temperature to –20°C, conditions that can be
accommodated in most residential dwellings.
However, in terms of home-based collection,
blood is somewhat problematic in that realis-
tically it takes visits by trained phlebotomists
to obtain samples. The only benefit this
might offer is convenience for study partici-
pants, which might increase participation
rates/decrease drop-out rates in epidemiologic
studies.
Although urine and blood have formed
the mainstay of biospecimen collection in
most ﬁeld-based epidemiologic studies to date,
a number of other accessible biological sam-
ples can provide useful and complementary
information on a wide range of physiologic
indicators and toxicant exposures. Those
receiving the most attention include saliva and
semen. Studies have shown that these can pro-
vide information on hormone levels (saliva) as
well as information on testicular function and
chemical exposures (semen). These samples
are easy to collect and can be stored in the
home environment. 
Samples that are accessible and potentially
informative but have received relatively little
attention include breast milk, hair follicles,
buccal cells, nail clippings, and vaginal swabs.
Breast milk appears to be an obvious biospeci-
men for analysis in studies such as the National
Children’s Study that focus on child health. It
can be used to monitor body burdens in repro-
ductive-age women and it estimates in utero
and nursing-infant exposures. However, the
range of biochemical targets that can be
robustly measured in milk, the sensitivity of
milk-based assays, and the effects of storage on
such sensitivity have only recently started to be
properly assessed. 
This situation is much the same for hair
follicles and nail clippings, whose main use
may be to provide nucleic acid for gene expres-
sion proﬁling and gene polymorphism analysis,
respectively. It appears unlikely that nail clip-
pings will displace buccal cells as convenient
sources of DNA for sequencing and polymor-
phism analysis in studies of older children and
adults, as a substantial body of literature sug-
gests that buccal cells can be conveniently col-
lected, stored, and transported from the home
environment and provide high yields of good-
quality DNA. However, for studies of infants
and young children, the nail-clipping method
may be an ideal alternative.
Though home collection of biospecimens
appears to offer advantages over clinic-based
studies in terms of participation rates and
reduced costs in certain circumstances, deﬁni-
tive assessments of cost-benefit compared
with clinic-based studies are needed to verify
this assumption Also needed are formal assess-
ments of collection, storage, and other quality
control issues associated with home collec-
tion, particularly for the less-studied speci-
mens such as nails, buccal cells, or vaginal
swabs. When suitable operating procedures
have been deﬁned, the integration of a wider
range of biospecimens than has been the case
thus far has the potential to enhance the
robustness of epidemiologic studies by help-
ing to characterize the causes of adverse out-
comes and facilitate new approaches to
identifying biomarkers of exposure, effect,
and disease development.
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